Home

Michael Graves

CIK 1339978 · Interim Executive Chair & PEO · last filed 2023-12-22

Michael Graves is an Interim Executive Chair & PEO who has filed 14 SEC Form 4 insider transactions across 1 company since 2015. The most recent filing, for EGRX, was dated Dec 22, 2023. Across all open-market trades the lifetime net is +$56.7K, making them a net buyer over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

1

Total Filings

14

Lifetime Open-Market Net

$56.7K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted Interim Executive Chair & PEO 10,360 $2.14 $22.2K $56.7K 14 2023-12-22

Recent Filings

14 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2023-12-22 EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted Grant (A) — $0 EDGAR
2023-10-31 EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted Exer (M) +9,360 $46.2K EDGAR
2023-03-09 EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted Grant (A) — $0 EDGAR
2022-03-02 EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted Grant (A) — $0 EDGAR
2021-02-04 EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted Grant (A) — $0 EDGAR
2020-01-07 EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted Grant (A) — $0 EDGAR
2019-01-25 EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted Grant (A) — $0 EDGAR
2018-01-09 EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted Grant (A) — $0 EDGAR
2017-01-06 EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted Grant (A) — $0 EDGAR
2016-08-04 EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted Grant (A) — $0 EDGAR
Showing 1–10 of 14
Page 1 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.